NO20014850L - CML-terapi - Google Patents

CML-terapi

Info

Publication number
NO20014850L
NO20014850L NO20014850A NO20014850A NO20014850L NO 20014850 L NO20014850 L NO 20014850L NO 20014850 A NO20014850 A NO 20014850A NO 20014850 A NO20014850 A NO 20014850A NO 20014850 L NO20014850 L NO 20014850L
Authority
NO
Norway
Prior art keywords
cml therapy
cml
therapy
Prior art date
Application number
NO20014850A
Other languages
English (en)
Norwegian (no)
Other versions
NO20014850D0 (no
Inventor
Esther Helen Rose
Mary Ellen Rybak
Original Assignee
Schering Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Corp filed Critical Schering Corp
Publication of NO20014850D0 publication Critical patent/NO20014850D0/no
Publication of NO20014850L publication Critical patent/NO20014850L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/21—Interferons [IFN]
    • A61K38/212—IFN-alpha
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Hematology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Zoology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Oncology (AREA)
  • Diabetes (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
NO20014850A 1999-04-08 2001-10-05 CML-terapi NO20014850L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US28836999A 1999-04-08 1999-04-08
PCT/US2000/009038 WO2000061173A2 (en) 1999-04-08 2000-04-05 Use of pegylated interferon alpha in chronic myeloid leukemia (cml) therapy

Publications (2)

Publication Number Publication Date
NO20014850D0 NO20014850D0 (no) 2001-10-05
NO20014850L true NO20014850L (no) 2001-12-07

Family

ID=23106810

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20014850A NO20014850L (no) 1999-04-08 2001-10-05 CML-terapi

Country Status (21)

Country Link
EP (2) EP1043024B1 (de)
JP (2) JP2000309541A (de)
CN (1) CN1364089A (de)
AR (1) AR023390A1 (de)
AT (1) ATE297216T1 (de)
AU (2) AU777456B2 (de)
BR (1) BR0009642A (de)
CA (1) CA2303765A1 (de)
CO (1) CO5170411A1 (de)
DE (1) DE60020635T2 (de)
DK (1) DK1043024T3 (de)
ES (1) ES2243166T3 (de)
HU (1) HUP0200731A3 (de)
MY (1) MY127276A (de)
NO (1) NO20014850L (de)
NZ (1) NZ514417A (de)
PE (1) PE20010226A1 (de)
PT (1) PT1043024E (de)
TW (1) TWI271196B (de)
WO (1) WO2000061173A2 (de)
ZA (1) ZA200108172B (de)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2003020977A2 (en) * 2001-08-31 2003-03-13 The University Court Of The University Of Glasgow Nucleotide repeats assay

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5908621A (en) * 1995-11-02 1999-06-01 Schering Corporation Polyethylene glycol modified interferon therapy
TW517067B (en) * 1996-05-31 2003-01-11 Hoffmann La Roche Interferon conjugates

Also Published As

Publication number Publication date
CO5170411A1 (es) 2002-06-27
AU4451500A (en) 2000-11-14
WO2000061173A2 (en) 2000-10-19
PT1043024E (pt) 2005-10-31
DE60020635T2 (de) 2006-05-04
JP2000309541A (ja) 2000-11-07
AU2004242456A1 (en) 2005-01-20
ES2243166T3 (es) 2005-12-01
PE20010226A1 (es) 2001-02-26
AU2004242456B2 (en) 2007-02-15
EP1043024B1 (de) 2005-06-08
ZA200108172B (en) 2003-01-06
NO20014850D0 (no) 2001-10-05
HK1032348A1 (en) 2001-07-20
EP1043024A2 (de) 2000-10-11
HUP0200731A2 (en) 2002-08-28
EP1535624A1 (de) 2005-06-01
DE60020635D1 (de) 2005-07-14
EP1043024A3 (de) 2000-12-20
DK1043024T3 (da) 2005-07-04
AR023390A1 (es) 2002-09-04
BR0009642A (pt) 2002-01-08
ATE297216T1 (de) 2005-06-15
NZ514417A (en) 2003-10-31
HUP0200731A3 (en) 2002-09-30
TWI271196B (en) 2007-01-21
WO2000061173A3 (en) 2001-01-25
MY127276A (en) 2006-11-30
CA2303765A1 (en) 2000-10-08
JP2007070367A (ja) 2007-03-22
CN1364089A (zh) 2002-08-14
AU777456B2 (en) 2004-10-14

Similar Documents

Publication Publication Date Title
DK1637127T3 (da) Terapeutisk mikroskum
DE69924365D1 (de) Massagegerät
DE122007000064I2 (de) Erythropoietinkonjugate
DE19983871T1 (de) Fönvorrichtung
DE10084676T1 (de) Einmallanzettvorrichtung
ID27841A (id) Turunan-turunan biaril terapeutik
ATA51899A (de) Handstempel
NO20014490D0 (no) Medisinske blandinger
ATE357433T1 (de) 4-pyrimidinyl-n-acyl-l-phenylanine
PT1235558E (pt) Agentes terapeuticos
ATE297895T1 (de) 4-pyridinyl-n-acyl-l-phenylalanine
DE60017816D1 (de) Herzschrittmacher
DE69916133D1 (de) Elektro-neuro-adaptiver stimulator
DE60016600D1 (de) Herzschrittmacher
DE59911113D1 (de) Herzschrittmacher
DE50015795D1 (de) Sektionaltor
DE50000805D1 (de) Aufsitzspanner
DE10085008T1 (de) Oberflächenbehandlungsdüse
DE60013608D1 (de) Herzschrittmacher
DE19983890T1 (de) Ventiltaktgebungsjustiereinrichtung
DE50001640D1 (de) Nahfeldoptische untersuchungsvorrichtung
NO20016301D0 (no) Terapeutiske midler
DE60016452D1 (de) Herzschrittmacher
ATE440824T1 (de) Nitro-sulfobenzamide
DE10082008D2 (de) Ausbeulgerät

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application